Development a vaccine against coccidioidomycosis

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Garry Cole

Chiung-Yu Hung

Funded by

San Antonio Vaccine Development Center

Research Start Date

11/01/2014

Status

Active

Applied Research

Collaborative Project

Basic Research

Drug Discovery

Infectious Disease

Bioscience Research Panel